Skip to main content

Find Clinical Trials

Home
Conditions
Cytopenia

Clinical trial condition

Cytopenia

Explore clinical trials studying Cytopenia. Study availability and eligibility vary by location and protocol.

1,006 public trials 191 recruiting studies

Refine in advanced search Browse all conditions

Cytopenia trial results

Active, Not Recruiting

A Randomized, Double-blind, Placebo-controlled, and Multi-center Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia

NCT06199089

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +17 more
Locations: Chinese Academy of Medical Science and Blood Disease Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Active, Not Recruiting

Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study

NCT05396157

Conditions: Bleeding Hemorrhage, Blood Platelet Disorders, Cardiovascular Diseases, +17 more
Locations: Federico Carini Toronto, Ontario, Canada

View Trial Details

Active, Not Recruiting

Efficacy of Fresh Frozen Plasma (FFP) in Treating Thrombocytopenia in Dengue Patients

NCT06642493

Conditions: Arbovirus Infections, Blood Platelet Disorders, Cytopenia, +16 more
Locations: SheikhHasinaNIBPS Dhaka, Bangladesh

View Trial Details

Active, Not Recruiting

Continuous Versus Bolus Administration of G-CSF in Children With Cancer

NCT06145321

Conditions: Agranulocytosis, Cytopenia, Filgrastim, +9 more
Locations: Chang Gung Children Hospital Taoyuan, ROC, Taiwan

View Trial Details

Active, Not Recruiting

Eltrombopag for the Treatment of Thrombocytopenia Due to Low- and Intermediate Risk Myelodysplastic Syndromes

NCT02912208

Conditions: Blood Platelet Disorders, Bone Marrow Diseases, Cytopenia, +4 more
Locations: CHU Amiens Amiens, France

Centre d'Avignon Avignon, France

Hôpital de la Côte Basque Bayonne, France

Centre d'Avicenne, Hôpital d'Avicenne Bobigny, France

View all 64 locations

View Trial Details

Active, Not Recruiting

Long Term Safety Follow up of Haematopoietic Stem Cell Gene Therapy for the Wiskott Aldrich Syndrome

NCT02333760

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +13 more
Locations: Hopital Necker - Enfants Malades Paris, France

UCL Institute of Child Health London, United Kingdom

View Trial Details